{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:54:30Z","timestamp":1782226470600,"version":"3.54.5"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03305-5","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T22:04:20Z","timestamp":1754172260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of hub genes for psoriasis and thyroid cancer using bioinformatics analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"HaiXia","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JuPing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HaoChen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiYa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanHua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"issue":"3","key":"3305_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3305_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","volume":"41","author":"SR Rapp","year":"1999","unstructured":"Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3):401\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3305_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jaad.2016.07.065","volume":"76","author":"3J Takeshita","year":"2017","unstructured":"Takeshita 3J, Grewal,Sin\u00e9ad S. Langan, et al.psoriasis and comorbid diseases part I. Epidemiol J Am Acad Dermatol. 2017;76(3):393\u2013403.","journal-title":"Epidemiol J Am Acad Dermatol"},{"issue":"4","key":"3305_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jamadermatol.2020.0024","volume":"156","author":"S Vaengebjerg","year":"2020","unstructured":"Vaengebjerg S, Skov L, Egeberg A, Loft ND. Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis. JAMA Dermatology. 2020;156(4):421\u20139.","journal-title":"JAMA Dermatology"},{"issue":"35","key":"3305_CR5","first-page":"2687","volume":"155","author":"JH Olsen","year":"1993","unstructured":"Olsen JH, Frentz G, Moller H. Psoriasis and cancer. Ugeskr Laeger. 1993;155(35):2687\u201391.","journal-title":"Ugeskr Laeger"},{"issue":"1","key":"3305_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/ajd.12889","volume":"60","author":"M Rademaker","year":"2019","unstructured":"Rademaker M, Rubel DM, Agnew K, et al. Psoriasis and cancer. An australian\/new Zealand narrative. Australas J Dermatol. 2019;60(1):12\u20138.","journal-title":"Australas J Dermatol"},{"issue":"12","key":"3305_CR7","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jamadermatol.2019.3056","volume":"155","author":"AM Trafffford","year":"2019","unstructured":"Trafffford AM, Parisi R, Kontopantelis E, Griffiffiffiths CEM, Ashcroft DM. Association of psoriasis with the risk of developing or dying of cancer. JAMA Dermatology. 2019;155(12):1390\u2013403.","journal-title":"JAMA Dermatology"},{"key":"3305_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","volume":"48","author":"CD Seib","year":"2019","unstructured":"Seib CD, Sosa JA. Evolving Understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin. 2019;48:23\u201335.","journal-title":"Endocrinol Metab Clin"},{"key":"3305_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.21053\/ceo.2022.00605","volume":"15","author":"H-R Won","year":"2022","unstructured":"Won H-R, Koo BS. Active surveillance or surgery in papillary thyroid microcarcinoma: an ongoing controversy. Clin Exp Otorhinolaryngol. 2022;15:123\u20134.","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"3305_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1507\/endocrj.EJ17-0026","volume":"64","author":"T Takano","year":"2017","unstructured":"Takano T. Natural history of thyroid cancer. Endocr J. 2017;64:237\u201344.","journal-title":"Endocr J"},{"issue":"1","key":"3305_CR11","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"3305_CR12","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the united states, 1974\u20132013. JAMA. 2017;317(13):1338\u201348.","journal-title":"JAMA"},{"issue":"5","key":"3305_CR13","first-page":"525","volume":"20","author":"BA Kilfoy","year":"2009","unstructured":"Kilfoy BA, Zheng T, Holford TR, et al. International patterns and trends in thyroid cancer incidence, 1973\u20132002. Cancer Causes Control. 2009;20(5):525\u201331.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"3305_CR14","first-page":"7","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"3305_CR15","first-page":"66","volume":"59","author":"TB Crn\u02c7ci\u00b4c","year":"2020","unstructured":"Crn\u02c7ci\u00b4c TB, Toma\u0161 MI, Girotto N, Ivankovi\u00b4c SG. Risk factors for thyroid cancer: what do we know so far?? Acta Clin Croat. 2020;59:66\u201372.","journal-title":"Acta Clin Croat"},{"key":"3305_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.mce.2009.10.003","volume":"321","author":"V Guarino","year":"2010","unstructured":"Guarino V, Castellone MD, Avilla E, Melillo RM. Thyroid cancer and inflflammation. Mol Cell Endocrinol. 2010;321:94\u2013102.","journal-title":"Mol Cell Endocrinol"},{"key":"3305_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/1346-8138.14698","volume":"46","author":"JH Lee","year":"2019","unstructured":"Lee JH, Kim H, Han KD, Kim H-N, Park YM, Lee JY, Park Y-G, Lee YB. Cancer risk in 892 089 patients with psoriasis in korea: A nationwide population-based cohort study. J Dermatol. 2019;46:95\u2013102.","journal-title":"J Dermatol"},{"key":"3305_CR18","doi-asserted-by":"crossref","unstructured":"Kano Y, Chiba M, Yagita A et al. Complete resolution of psoriasis vulgaris after excision of thyroid cancer[. J] Int J Dermatol,36,0(1997).","DOI":"10.1111\/j.1365-4362.1997.tb03044.x"},{"key":"3305_CR19","doi-asserted-by":"crossref","unstructured":"Alexis R, Morgenstern,Liam F, Peterson,Kimberly A, Arnold et al. Differentiation of keratinocytes or exposure to type 2 cytokines diminishes S. aureus internalization.[J].mSphere, 9,0(2024).","DOI":"10.1128\/msphere.00685-23"},{"key":"3305_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12885-020-07721-4","volume":"21","author":"Y Xu","year":"2021","unstructured":"Xu Y, Wang Y, Liu H. Bioinformatics analysis to screen the key prognostic genes and pathways in hepatocellular carcinoma. BMC Cancer. 2021;21:17.","journal-title":"BMC Cancer"},{"key":"3305_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207\u201310. https:\/\/doi.org\/10.1093\/nar\/30.1.207.","journal-title":"Nucleic Acids Res"},{"key":"3305_CR22","doi-asserted-by":"crossref","unstructured":"Ojha Madhavi,Manocha Nilanshu,Madaan Alka. Anti-psoriatic potential of medicinal plants, Alstonia scholaris, Wrightia tinctoria, and solanum xanthocarpum, using human HaCaT keratinocytes by multi-parametric analysis. [J] J Ethnopharmacol, 334,118596(2024).","DOI":"10.1016\/j.jep.2024.118596"},{"key":"3305_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1365-2133.2010.10182.x","volume":"164","author":"MN de Koning","year":"2011","unstructured":"de Koning MN, C,Polderman MC, A,Waterboer T, et al. Marked differences in betapapillomavirus DNA and antibody prevalence between patients with psoriasis and those with atopic dermatitis.[J]. Br J Dermatol. 2011;164:771\u201352011.","journal-title":"Br J Dermatol"},{"key":"3305_CR24","doi-asserted-by":"crossref","unstructured":"Hansen A. Ree,Annette Torgunrud, Kristensen,Marie Gr\u00f8n, Saelen Tumor phosphatidylinositol-3-kinase signaling and development of metastatic disease in locally advanced rectal cancer.[J].PLoS One. 7,0(2012).","DOI":"10.1371\/journal.pone.0050806"},{"key":"3305_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/gb-2006-7-5-216","volume":"7","author":"RH Law","year":"2006","unstructured":"Law RH, Zhang Q, McGowan S, Buckle AM, Silverman GA, et al. An overview of the Serpin superfamily. Genome Biol. 2006;7:216.","journal-title":"Genome Biol"},{"key":"3305_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0925-4439(01)00025-4","volume":"1535","author":"S Janciauskiene","year":"2001","unstructured":"Janciauskiene S. Conformational properties of Serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim Biophys. 2001;1535:221\u201335.","journal-title":"Biochim Biophys"},{"key":"3305_CR27","doi-asserted-by":"crossref","unstructured":"Li QDX,Jin, Gebing et al. Identification of Serpin peptidase inhibitor clade A member 1 (SERPINA1) might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer.[J].Life Sci.329,121938(2023).","DOI":"10.1016\/j.lfs.2023.121938"},{"key":"3305_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1755-8794-4-30","volume":"4","author":"K Vierlinger","year":"2011","unstructured":"Vierlinger K, Mansfeld MH, Koperek O, Nohammer C, Kaserer K, et al. Identification of SERPINA1 as single marker for papillary thyroid carcinoma through microarray meta analysis and quantification of its discriminatory power in independent validation. BMC Med Genom. 2011;4:30.","journal-title":"BMC Med Genom"},{"key":"3305_CR29","doi-asserted-by":"crossref","unstructured":"Kantaputra Piranit,Daroontum Teerada,Chuamanochan, Mati et al. SERPINB3, Adult-Onset Immunodeficiency, and Generalized Pustular Psoriasis.[J].Genes (Basel).14,undefined(2023).","DOI":"10.3390\/genes14020266"},{"key":"3305_CR30","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.jid.2019.11.024","volume":"140","author":"S Frey","year":"2020","unstructured":"Frey S, Sticht H, Wilsmann-Theis D, Gersch\u00fctz A, Wolf K, L\u00f6hr S, et al. Rare loss-of-function mutation in SERPINA3 in generalized pustular psoriasis. J Invest Dermatol. 2020;140:1451\u20135.","journal-title":"J Invest Dermatol"},{"key":"3305_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaci.2016.08.056","volume":"140","author":"A Johnston","year":"2017","unstructured":"Johnston A, Xing X, Wolterink L, Barnes DH, Yin Z, Reingold L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140:109\u201320.","journal-title":"J Allergy Clin Immunol"},{"key":"3305_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41423-020-0519-3","volume":"18","author":"R Uppala","year":"2021","unstructured":"Uppala R, Tsoi LC, Harms PW, Wang B, Billi AC, Maverakis E, et al. Autoinflammatory psoriasis genetics and biology of pustular psoriasis. Cell Mol Immunol. 2021;18:307\u201317.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"3305_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1084\/jem.186.6.837","volume":"186","author":"DR Greaves","year":"1997","unstructured":"Greaves DR, Wang W, Dairaghi DJ, Dieu MC, Saint-Vis B, Franz-Bacon K, et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med. 1997;186(6):837\u201344.","journal-title":"J Exp Med"},{"issue":"5","key":"3305_CR34","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03699.x","volume":"72","author":"M Muzza","year":"2010","unstructured":"Muzza M, Degl\u2019Innocenti D, Colombo C, Perrino M, Ravasi E, Rossi S, et al. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf). 2010;72(5):702\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"3305_CR35","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1046\/j.1365-3083.2003.01263.x","volume":"57","author":"J Dellacasagrande","year":"2003","unstructured":"Dellacasagrande J, Schreurs OJ, Hofgaard PO, Omholt H, Steinsvoll S, Schenck K, et al. Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scand J Immunol. 2003;57(6):534\u201344.","journal-title":"Scand J Immunol"},{"key":"3305_CR36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1042\/BJ20071493","volume":"409","author":"M O\u2019Hayre","year":"2008","unstructured":"O\u2019Hayre M, Salanga CL, Handel TM, et al. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J. 2008;409:635\u201349.","journal-title":"Biochem J"},{"key":"3305_CR37","first-page":"9","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, et al. Cancer statistics. CA Cancer J Clin. 2014;64:9\u201329. (2014).","journal-title":"CA Cancer J Clin"},{"key":"3305_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yexcr.2011.10.012","volume":"318","author":"N Mukaida","year":"2012","unstructured":"Mukaida N, Baba T. Chemokines in tumor development and progression. Exp Cell Res. 2012;318:95\u2013102.","journal-title":"Exp Cell Res"},{"issue":"4","key":"3305_CR39","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1007\/s13277-015-4418-7","volume":"37","author":"F Coperchini","year":"2016","unstructured":"Coperchini F, Pignatti P, Carbone A, Bongianino R, Di Buduo CA, Leporati P, Croce L, Magri F, Balduini A, Chiovato L, Rotondi M. TNF-\u03b1 increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer. Tumour Biol. 2016;37(4):5569\u201375.","journal-title":"Tumour Biol"},{"issue":"3","key":"3305_CR40","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0002-9440(10)64951-6","volume":"156","author":"S Scarpino","year":"2000","unstructured":"Scarpino S, Stoppacciaro A, Ballerini F, Marchesi M, Prat M, Stella MC, et al. Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells. Am J Pathol. 2000;156(3):831\u20137.","journal-title":"Am J Pathol"},{"issue":"19","key":"3305_CR41","first-page":"6478","volume":"63","author":"E Hartmann","year":"2003","unstructured":"Hartmann E, Wollenberg B, Rothenfusser S, Wagner M, Wellisch D, Mack B, et al. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 2003;63(19):6478\u201387.","journal-title":"Cancer Res"},{"issue":"10","key":"3305_CR42","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1084\/jem.190.10.1417","volume":"190","author":"D Bell","year":"1999","unstructured":"Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S, et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med. 1999;190(10):1417\u201326.","journal-title":"J Exp Med"},{"issue":"12","key":"3305_CR43","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/nm1201-1339","volume":"7","author":"W Zou","year":"2001","unstructured":"Zou W, Machelon V, Coulomb-L\u2019Hermin A, Borvak J, Nome F, Isaeva T, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med. 2001;7(12):1339\u201346.","journal-title":"Nat Med"},{"issue":"3","key":"3305_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/ajcp\/89.3.295","volume":"89","author":"S Schr\u00f6der","year":"1988","unstructured":"Schr\u00f6der S, Schwarz W, Rehpenning W, L\u00f6ning T, B\u00f6cker W. Dendritic\/ Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol. 1988;89(3):295\u2013300.","journal-title":"Am J Clin Pathol"},{"key":"3305_CR45","doi-asserted-by":"publisher","first-page":"e12846","DOI":"10.1111\/sji.12846","volume":"91","author":"K Furue","year":"2020","unstructured":"Furue K, Ito T, Tsuji G, Nakahara T, Furue M. The CCL20 and CCR6 axis in psoriasis. Scand J Immunol. 2020;91:e12846.","journal-title":"Scand J Immunol"},{"key":"3305_CR46","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140:645\u201353.","journal-title":"J Allergy Clin Immunol"},{"key":"3305_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2133.2011.10302.x","volume":"165","author":"P Muhr","year":"2011","unstructured":"Muhr P, Zeitvogel J, Heitland I, Werfel T, Wittmann M. Expression of Interleukin (IL)-1 family members upon stimulation with IL-17 differs in keratinocytes derived from patients with psoriasis and healthy donors. Br J Dermatol. 2011;165:189\u201393.","journal-title":"Br J Dermatol"},{"key":"3305_CR48","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jid.2018.07.036","volume":"139","author":"S Yu","year":"2019","unstructured":"Yu S, Wu X, Zhou Y, Han D, Anderson LS, Simon SI, et al. Is CCR6 required for the development of psoriasiform dermatitis in mice? J Invest Dermatol. 2019;139:485\u20138.","journal-title":"J Invest Dermatol"},{"key":"3305_CR49","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/jid.2013.534","volume":"134","author":"TG Kim","year":"2014","unstructured":"Kim TG, Jee H, Fuentes-Duculan J, Wu WH, Byamba D, Kim DS, et al. Dermal clusters of mature dendritic cells and T cells are associated with the CCL20\/CCR6 chemokine system in chronic psoriasis. J Invest Dermatol. 2014;134:1462\u20135.","journal-title":"J Invest Dermatol"},{"key":"3305_CR50","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1172\/JCI37378","volume":"119","author":"MN Hedrick","year":"2009","unstructured":"Hedrick MN, Lonsdorf AS, Shirakawa AK, Richard Lee CC, Liao F, Singh SP, et al. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest. 2009;119:2317\u201329.","journal-title":"J Clin Invest"},{"key":"3305_CR51","doi-asserted-by":"crossref","unstructured":"Brunner PM, Suarez-Farinas M, He H, Malik K, Wen HC, Gonzalez J et al. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins. Sci Rep.7,8707(2017).","DOI":"10.1038\/s41598-017-09207-z"},{"key":"3305_CR52","doi-asserted-by":"crossref","unstructured":"Kim KE, Houh Y, Park HJ, Cho D. Therapeutic effects of erythroid differentiation regulator 1 on imiquimod-induced psoriasis-like skin inflammation. Int J Mol Sci17,244(2016).","DOI":"10.3390\/ijms17020244"},{"key":"3305_CR53","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.4049\/jimmunol.1101817","volume":"187","author":"T Mabuchi","year":"2011","unstructured":"Mabuchi T, Takekoshi T, Hwang ST, Epidermal. CCR6\u2009+\u2009gammadelta T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J Immunol. 2011;187:5026\u201331.","journal-title":"J Immunol"},{"key":"3305_CR54","doi-asserted-by":"crossref","unstructured":"Aguilar-Flores C, Castro-Escamilla O, Ortega-Rocha EM, Maldonado-Garcia C, Jurado-Santa Cruz F, Perez-Montesinos G et al. Association of pathogenic Th17 cells with the disease severity and its potential implication for biological treatment selection in psoriasis patients. Mediators Inflamm.8065147(2020).","DOI":"10.1155\/2020\/8065147"},{"key":"3305_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.imlet.2020.11.005","volume":"229","author":"W Liu","year":"2021","unstructured":"Liu W, Zhou X, Wang A, Ma J, Bai Y. Increased peripheral helper T cells type 17 subset correlates with the severity of psoriasis vulgaris. Immunol Lett. 2021;229:48\u201354.","journal-title":"Immunol Lett"},{"key":"3305_CR56","doi-asserted-by":"crossref","unstructured":"Robert R, Ang C, Sun G, Juglair L, Lim EX, Mason LJ et al. Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice. JCI Insight.2(2017).","DOI":"10.1172\/jci.insight.94821"},{"key":"3305_CR57","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jamadermatol.2015.0452","volume":"151","author":"AM Goldminz","year":"2015","unstructured":"Goldminz AM, Suarez-Farinas M, Wang AC, Dumont N, Krueger JG, Gottlieb AB. CCL20 and IL22 messenger RNA expression after adalimumab vs methotrexate treatment of psoriasis: a randomized clinical trial. JAMA Dermatol. 2015;151:837\u201346.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"3305_CR58","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5114\/pjp.2014.45782","volume":"65","author":"H Ma","year":"2014","unstructured":"Ma H, Xu S, Yan J, Zhang C, Qin S, Wang X, Li N. The value of tumour markers in the diagnosis of papillary thyroid carcinoma alone and in combination. Pol J Pathol. 2014;65(3):202\u20139.","journal-title":"Pol J Pathol"},{"key":"3305_CR59","doi-asserted-by":"crossref","unstructured":"Alkaya Mustafa,Bayram Ali,Ya\u015far, Mehmet et al. Lipocalin-2 expression in papillary thyroid carcinoma and its association with clinicopathological characteristics.[J].Eur Arch Otorhinolaryngol.undefined(2024).","DOI":"10.1007\/s00405-024-08954-w"},{"issue":"1","key":"3305_CR60","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12885-017-3948-3","volume":"18","author":"R Celestino","year":"2018","unstructured":"Celestino R, Nome T, Pestana A, Hoff AM, Gon\u00e7alves AP, Pereira L, Cavadas B, Eloy C, Bj\u00f8ro T, Sobrinho-Sim\u00f5es M, Skotheim RI. Soares PCRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension. BMC Cancer. 2018;18(1):68.","journal-title":"BMC Cancer"},{"issue":"8","key":"3305_CR61","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.jid.2022.01.012","volume":"142","author":"J Ma","year":"2022","unstructured":"Ma J, Chen J, Xue K, Yu C, Dang E, Qiao H, et al. LCN2 mediates skin inflflammation in psoriasis through the SREBP2NLRC4 axis. J Invest Dermatol. 2022;142(8):2194\u2013204.","journal-title":"J Invest Dermatol"},{"key":"3305_CR62","doi-asserted-by":"crossref","unstructured":"Xing Meng,Yan Xiaoning,Guo Jiangtao. ViaBanzhilian formula alleviates psoriasis-like lesions the LCN2\/MMP-9 axis based on transcriptome analysis[. J] Front Pharmacol.14,1055363(2023).","DOI":"10.3389\/fphar.2023.1055363"},{"key":"3305_CR63","doi-asserted-by":"publisher","first-page":"14058","DOI":"10.1073\/pnas.0710846105","volume":"105","author":"A Lannetti","year":"2008","unstructured":"Lannetti A, Pacifico F, Acquaviva R, et al. The neutrophil gelatinase-associated Lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci USA. 2008;105:14058\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3305_CR64","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s00405-018-5118-x","volume":"275","author":"Tai Jun,Wang Shengcai,Zhang Jie","year":"2018","unstructured":"Tai Jun,Wang Shengcai,Zhang Jie. Up-regulated lipocalin-2 in pediatric thyroid cancer correlated with poor clinical characteristics.[J]. Eur Arch Otorhinolaryngol. 2018;275:2823\u20138.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"8","key":"3305_CR65","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/jid.2015.103","volume":"135","author":"P Nikamo","year":"2015","unstructured":"Nikamo P, Lysell J, St\u00e5hle M. Association with genetic variants in the IL-23 and NF-\u03baB pathways discriminates between mild and severe psoriasis skin disease. J Invest Dermatol. 2015;135(8):1969\u201376.","journal-title":"J Invest Dermatol"},{"key":"3305_CR66","doi-asserted-by":"crossref","unstructured":"Elbadawy HM, Borthwick F, Wright C et al. Cytosolic StAR-related lipid transfer domain 4 (STARD4) protein influences keratinocyte lipid phenotype and differentiation status[. J] Br J Dermatol.164,628\u2013\u200932(2011).","DOI":"10.1111\/j.1365-2133.2010.10102.x"},{"key":"3305_CR67","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1089\/thy.2016.0285","volume":"27","author":"Weinberger Paul,Ponny Sithara Raju,Xu Hongyan","year":"2017","unstructured":"Weinberger Paul,Ponny Sithara Raju,Xu Hongyan. Cell cycle M-Phase genes are highly upregulated in anaplastic thyroid carcinoma. [J] Thyroid. 2017;27:236\u201352.","journal-title":"[J] Thyroid"},{"key":"3305_CR68","doi-asserted-by":"crossref","unstructured":"Hossain Md Ali,Asa Tania Akter,Rahman Md Mijanur. Network-Based genetic profiling reveals cellular pathway differences between follicular thyroid carcinoma and follicular thyroid Adenoma.[J]. Int J Environ Res Public Health.7,undefined(2020).","DOI":"10.3390\/ijerph17041373"},{"key":"3305_CR69","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1016\/j.jid.2022.03.013","volume":"142","author":"Tom","year":"2022","unstructured":"Bridgewood Charlie,Wittmann Miriam,Macleod, Tom, et al. T helper 2 IL-4\/IL-13 dual Blockade with dupilumab is linked to some emergent T helper 17\u2013Type diseases, including seronegative arthritis and enthesitis\/enthesopathy, but not to humoral autoimmune Diseases.[J]. J Invest Dermatol. 2022;142:2660\u20137.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"3305_CR70","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3109\/0284186X.2016.1157264","volume":"55","author":"L Marchand","year":"2016","unstructured":"Marchand L, Nozi\u00e8res C, Walter T, Descotes F, Decaussin-Petrucci M, Joly MO, Lapras V, Bournaud C, Borson-Chazot F. Combination chemotherapy with 5-fluorouracil and Dacarbazine in advanced medullary thyroid cancer, a possible alternative? Acta Oncol. 2016;55(8):1064\u20136.","journal-title":"Acta Oncol"},{"key":"3305_CR71","doi-asserted-by":"crossref","unstructured":"Zongfu P, Xixuan L, Xi H et al. Disrupting Glycolysis and DNA repair in anaplastic thyroid cancer with nucleus-targeting platinum nanoclusters[. J] J Control Release.369,0(2024).","DOI":"10.1016\/j.jconrel.2024.03.057"},{"key":"3305_CR72","doi-asserted-by":"crossref","unstructured":"Sekhar Konjeti R. Hanna David N,Cyr Sriram Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer.[J].Sci Rep.12,19396(2022).","DOI":"10.1038\/s41598-022-23906-2"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03305-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03305-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03305-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:53:08Z","timestamp":1757335988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03305-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3305"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03305-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1460"}}